Market research
ALPRE.PA Predilife S.A
PA EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 20.92
- Dividend yield
- Not available
- Beta
- 0.25
Profile
Company facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- FR0010169920
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 20.92
- Dividend yield
- Not available
- Beta
- 0.25
About
About Predilife S.A
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ALPRE.PA discussion.
5 years, 5 months ago
Predilife S.A is currently in a long term downtrend where the price is trading 4.9% below its 200 day moving average.
From a valuation standpoint, the stock is 66.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 92.2.
Based on the above factors, Predilife S.A gets an overall score of 1/5.